SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Improving the Treatment of Neonatal Sepsis in Resource-Limited Settings: Gaps and Recommendations.

Sturrock, S; Sadoo, S; Nanyunja, C; Le Doare, K (2023) Improving the Treatment of Neonatal Sepsis in Resource-Limited Settings: Gaps and Recommendations. Res Rep Trop Med, 14. pp. 121-134. ISSN 1179-7282 https://doi.org/10.2147/RRTM.S410785
SGUL Authors: Le Doare, Kirsty

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (702kB) | Preview

Abstract

Neonatal sepsis causes significant global morbidity and mortality, with the highest burden in resource-limited settings where 99% of neonatal deaths occur. There are multiple challenges to achieving successful treatment of neonates in this setting. Firstly, reliable and low-cost strategies for risk identification are urgently needed to facilitate treatment as early as possible. Improved laboratory capacity to allow identification of causative organisms would support antimicrobial stewardship. Antibiotic treatment is still hampered by availability, but also increasingly by antimicrobial resistance - making surveillance of organisms and judicious antibiotic use a priority. Finally, supportive care is key in the management of the neonate with sepsis and has been underrecognized as a priority in resource-limited settings. This includes fluid balance and nutritional support in the acute phase, and follow-up care in order to mitigate complications and optimise long-term outcomes. There is much more work to be done in identifying the holistic needs of neonates and their families to provide effective family-integrated interventions and complete the package of neonatal sepsis management in resource-limited settings.

Item Type: Article
Additional Information: © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (https://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Keywords: antimicrobial resistance, low- and middle-income countries, neonate, outcomes, sepsis, neonate, low, and middle-income countries, antimicrobial resistance, outcomes, sepsis, 1108 Medical Microbiology, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Res Rep Trop Med
ISSN: 1179-7282
Language: eng
Dates:
DateEvent
14 December 2023Published
29 November 2023Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 3.0
Projects:
Project IDFunderFunder ID
228357/Z/23/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 38116466
Web of Science ID: WOS:001126097600001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115956
Publisher's version: https://doi.org/10.2147/RRTM.S410785

Actions (login required)

Edit Item Edit Item